Abstract:Importance:Image-guided thermal ablation has been administered for patients with T1N0M0 papillary thyroid carcinoma (PTC) who elect to not undergo surgery or receive active surveillance. Considering the indolent nature of PTC, long-term outcomes of ablation are needed. Objective:To investigate l0-year outcomes of thermal ablation in treating T1N0M0 PTC. Design, Setting, and Participants:This multicenter study was conducted at 4 university-affiliated hospitals in China and included 179 consecutive patients with T1N0M0 PTC (median [IQR] volume, 88.0 [163.2] mm3) who underwent thermal ablation between June 2010 and March 2014. Patients who were ineligible to undergo surgery or elected not to were included, and patients had PTC tumors that were smaller than 20 mm as confirmed by biopsy; no clinical or imaging evidence of extrathyroidal extension, lymph node metastasis (LNM), or distant metastasis; and no history of neck irradiation. Main Outcomes and Measures:The primary outcomes were disease progression (LNM, newly developed tumors, persistent tumors, and distant metastasis) and disease-free survival (DFS). Secondary outcomes were technical success, volume reduction rate, tumor disappearance, complications, and delayed surgery. DFS was calculated using a Kaplan-Meier analysis. Results:Among the 179 patients, the mean (SD) age was 45.8 (12.7) years, and 118 (65.9%) were female. During a mean (SD) follow-up period of 120.8 (10.8) months, disease progression was found in 11 of 179 patients (6.1%), including LNM in 4 patients (2.2%), newly developed tumors in 6 patients (3.3%), and persistent tumor in 1 patient (0.6%). The 10-year DFS was 93.9%. The technical success, median volume reduction rate, and tumor disappearance rate was 100%, 100%, and 97.2%, respectively. The magnitude of the disease progression (6.1% vs 7.1%; difference, 1.0%; 95% CI, -6.5% to 25.6%) and DFS (93.9% vs 92.9%; difference, 1.0%, 95% CI, -6.5% to 25.6%) between patients with T1a and T1b tumors was small. The difference in the rate of tumor disappearance between T1a and T1b tumors was large (99.4% vs 71.4%; difference, 28.0%; 95% CI, 10.9%-54.0%). One patient experienced transient voice hoarseness (0.6%). Because of anxiety, 1 patient underwent delayed surgery (0.6%). Conclusions and Relevance:The results of this 10-year multicenter cohort study suggest that thermal ablation is an effective and safe alternative for patients with T1N0M0 PTC who do not undergo surgery or receive active surveillance. For safe and effective treatment, accurate radiologic evaluation, an understanding of ablation techniques, and experienced physicians are recommended.

Residual tumor and central lymph node metastasis after thermal ablation of papillary thyroid carcinoma: A case report and review of literature

Expert Consensus Workshop Report: Guidelines for Thermal Ablation of Thyroid Tumors (2019 Edition)

Thermal Ablation for Papillary Thyroid Microcarcinoma: How Far We Have Come?

Surgical Confirmation of Incomplete Treatment for Primary Papillary Thyroid Carcinoma by Percutaneous Thermal Ablation: A Retrospective Case Review and Literature Review.

Safety and Efficacy of Ultrasound-Guided Thermal Ablation in Treating T1aN0M0 and T1bN0M0 Papillary Thyroid Carcinoma: A Meta-Analysis

Research Review of Thermal Ablation in the Treatment of Papillary Thyroid Carcinoma

Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma

Thermal Ablation for Papillary Thyroid Carcinoma

Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study

Efficacy and Safety of Thermal Ablation for Treatment of Solitary T1N0M0 Papillary Thyroid Carcinoma: A Multicenter Retrospective Study

Ultrasonography-guided thermal ablation for cervical lymph node metastasis of papillary thyroid carcinoma: Is it superior to surgical resection?

Thermal ablation for the treatment of malignant thyroid nodules: present and future

Efficacy and Safety of Percutaneous Ultrasound-Guided Microwave Ablation for Cervical Metastatic Lymph Nodes from Papillary Thyroid Carcinoma.

Thermal Ablation for Papillary Thyroid Microcarcinoma Located in the Isthmus: a Study with 3 Years of Follow-Up

Thermal Ablation in Treatment of Benign and Malignant Thyroid Tumors: Current Status and Future Perspectives

Efficacy And Safety Of Thermal Ablation For Treatment Of Solitary T1n0m0 Papillary Thyroid Carcinoma: Multicenter Retrospective Study

Surgery after Ultrasound-Guided Radiofrequency Ablation for Papillary Thyroid Carcinoma in 21 Patients: A Retrospective Study from a Single Center in China

US-guided Microwave Ablation of Low-Risk Papillary Thyroid Microcarcinoma: Longer-Term Results of a Prospective Study

Efficacy and safety of percutaneous ultrasound-guided thermal ablation in the treatment of cervical metastatic lymph nodes from papillary thyroid carcinoma

Comparison between thermal ablation and surgery in low risk papillary thyroid carcinoma: a prospective study

Ultrasound-guided radiofrequency ablation for the treatment of papillary thyroid carcinoma: a review of the current state and future perspectives